CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pharmaron Beijing Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pharmaron Beijing Co Ltd
No. 6 Taihe Road, Beijing Economic and T
Phone: +86 1057330087p:+86 1057330087 BEIJING, BEJ  100176  China Ticker: 300759300759
Business Summary
Pharmaron Beijing Co Ltd is a China-based company providing research and manufacturing service portfolio, medical tools and clinical research testing services in the process of discovering, developing and manufacturing small molecule drugs, cell therapy and gene therapy. The Company operates in four segments. Laboratory Services segment includes laboratory chemistry, drug metabolism and pharmacokinetics/absorption, distribution, metabolism and excretion, biology, safety assessment and discovery of biological agents. CMC Service segment is engaged in process development and preform production and analysis. Clinical Development Service segment includes clinical research, on-site management organization, regulatory biological analysis and radioactive labeling scientific services. The Biologics and CGT Services segment is engaged in the discovery, development and production of macromolecular drugs, development of cell gene therapy methods and other businesses.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer BoliangLou 60 10/27/2016 10/27/2016
President, Chief Operating Officer, Executive Director XiaoqiangLou 55 7/7/2023 10/27/2016
Chief Financial Officer, Secretary of the Board Shing ChungLi 45 10/27/2016 1/1/2015
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Aesica Pharmaceuticals Limited Windmill Industrial Estate Cramlington United Kingdom
TGA Sciences, Inc. 47 Hall Street Medford MA United States
Absorption Systems LP 436 Creamery Way, Suite 600 Exton PA United States

Business Names
Business Name
300759
3759
Absorption Systems LP
Aesica Pharmaceuticals Limited
TGA Sciences, Inc.

General Information
Number of Employees: 20,295 (As of 12/31/2023)
Outstanding Shares: 1,787,394,297 (As of 9/30/2024)
Shareholders: 82,267
Stock Exchange: SHE
Fax Number: +86 1057330087


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024